ATE457160T1 - Vanillin-polymere zwecks verwendung zur verdunklung der haut - Google Patents

Vanillin-polymere zwecks verwendung zur verdunklung der haut

Info

Publication number
ATE457160T1
ATE457160T1 AT04813962T AT04813962T ATE457160T1 AT E457160 T1 ATE457160 T1 AT E457160T1 AT 04813962 T AT04813962 T AT 04813962T AT 04813962 T AT04813962 T AT 04813962T AT E457160 T1 ATE457160 T1 AT E457160T1
Authority
AT
Austria
Prior art keywords
skin
darken
vanillin
polymers
vanillin polymers
Prior art date
Application number
AT04813962T
Other languages
English (en)
Inventor
Connie Baozhen Lin
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Application granted granted Critical
Publication of ATE457160T1 publication Critical patent/ATE457160T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT04813962T 2003-12-12 2004-12-09 Vanillin-polymere zwecks verwendung zur verdunklung der haut ATE457160T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/735,540 US7935331B2 (en) 2003-12-12 2003-12-12 Vanillin polymers for use in darkening the skin
PCT/US2004/041716 WO2005058262A1 (en) 2003-12-12 2004-12-09 Vanillin polymers for use in darkening the skin

Publications (1)

Publication Number Publication Date
ATE457160T1 true ATE457160T1 (de) 2010-02-15

Family

ID=34653644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04813962T ATE457160T1 (de) 2003-12-12 2004-12-09 Vanillin-polymere zwecks verwendung zur verdunklung der haut

Country Status (6)

Country Link
US (1) US7935331B2 (de)
EP (1) EP1701689B1 (de)
AT (1) ATE457160T1 (de)
CA (1) CA2547762C (de)
DE (1) DE602004025507D1 (de)
WO (1) WO2005058262A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8278359B2 (en) 2005-02-25 2012-10-02 Johnson & Johnson Consumer Companies, Inc. Compositions containing amines and use thereof to treat acne or reduce the appearance of oil or pores on the skin
EP2011471A1 (de) * 2007-07-02 2009-01-07 Johnson & Johnson Consumer France SAS Schäumende Ölzubereitungen
WO2009005151A1 (ja) 2007-07-05 2009-01-08 Nissan Chemical Industries, Ltd. 新規脂質ペプチド並びにヒドロゲル
US20090087395A1 (en) 2007-10-01 2009-04-02 Lin Connie B Compositions for use in darkening the skin
US8481006B2 (en) * 2008-04-25 2013-07-09 New Sunshine, Llc Melt formula
IT1394672B1 (it) * 2009-02-11 2012-07-13 Wellpharma S R L Preparazione topica
CN105664223B (zh) * 2009-10-26 2018-12-04 日产化学工业株式会社 化妆料、皮肤外用剂、以及医疗用仪器
US9475709B2 (en) 2010-08-25 2016-10-25 Lockheed Martin Corporation Perforated graphene deionization or desalination
EP2898875A1 (de) * 2010-09-22 2015-07-29 L'oreal Neue Ortho-Diphenolderivate, kosmetische Zusammensetzung damit und kosmetisches Behandlungsverfahren
KR101769456B1 (ko) 2011-05-26 2017-08-30 주식회사 엘지생활건강 유통기한의 경과에 대한 표시 기능을 가진 화장료 조성물
US9610546B2 (en) 2014-03-12 2017-04-04 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US9844757B2 (en) 2014-03-12 2017-12-19 Lockheed Martin Corporation Separation membranes formed from perforated graphene and methods for use thereof
US9744617B2 (en) 2014-01-31 2017-08-29 Lockheed Martin Corporation Methods for perforating multi-layer graphene through ion bombardment
US9834809B2 (en) 2014-02-28 2017-12-05 Lockheed Martin Corporation Syringe for obtaining nano-sized materials for selective assays and related methods of use
US10376845B2 (en) 2016-04-14 2019-08-13 Lockheed Martin Corporation Membranes with tunable selectivity
US10653824B2 (en) 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
TW201504140A (zh) 2013-03-12 2015-02-01 Lockheed Corp 形成具有均勻孔尺寸之多孔石墨烯之方法
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
CN106029596A (zh) 2014-01-31 2016-10-12 洛克希德马丁公司 采用多孔非牺牲性支撑层的二维材料形成复合结构的方法
CN105940479A (zh) 2014-01-31 2016-09-14 洛克希德马丁公司 使用宽离子场穿孔二维材料
JP2017534311A (ja) 2014-09-02 2017-11-24 ロッキード・マーチン・コーポレーション 二次元膜材料をベースとする血液透析膜および血液濾過膜、ならびにそれを用いた方法
JP2018528144A (ja) 2015-08-05 2018-09-27 ロッキード・マーチン・コーポレーション グラフェン系材料の穿孔可能なシート
WO2017023377A1 (en) 2015-08-06 2017-02-09 Lockheed Martin Corporation Nanoparticle modification and perforation of graphene
EP3442697A4 (de) 2016-04-14 2020-03-18 Lockheed Martin Corporation Selektive grenzflächenminderung von graphendefekten
EP3442739A4 (de) 2016-04-14 2020-03-04 Lockheed Martin Corporation Verfahren zur behandlung von graphenfolien für grossflächigen transfer mittels free-float-verfahren
WO2017180134A1 (en) 2016-04-14 2017-10-19 Lockheed Martin Corporation Methods for in vivo and in vitro use of graphene and other two-dimensional materials
KR20180133430A (ko) 2016-04-14 2018-12-14 록히드 마틴 코포레이션 결함 형성 또는 힐링의 인 시츄 모니터링 및 제어를 위한 방법
EP3442786A4 (de) 2016-04-14 2020-03-18 Lockheed Martin Corporation Zweidimensionale membranstrukturen mit strömungskanälen
KR102260329B1 (ko) 2019-08-05 2021-06-02 주식회사 엘지생활건강 발수 및 발유 특성이 동시에 우수한 고분자 피막제 및 이를 포함하는 화장 지속성이 우수한 화장료 조성물
AU2021262776A1 (en) 2020-04-29 2022-09-29 Kao Corporation Self-tanning compositions containing an alkyl sulfonate and methods thereof
AU2021265114A1 (en) 2020-04-29 2022-11-24 Kao Corporation Self-tanning compositions containing an aromatic sulfonate and methods thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553146A (en) 1946-09-13 1951-05-15 Sulphite Products Corp Production of vanillic acid
US4230817A (en) * 1979-03-02 1980-10-28 Celanese Corporation Thermotropic polyesters derived from ferulic acid and a process for preparing the polyesters
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US4714609A (en) * 1986-07-21 1987-12-22 Laverne Stanley Skin tanning composition
US5013497A (en) * 1988-03-03 1991-05-07 Micro-Pak, Inc. Method and apparatus for producing lipid vesicles
US5216116A (en) * 1990-05-18 1993-06-01 Yale University Soluble melanin
US5218079A (en) * 1990-05-18 1993-06-08 Yale University Soluble melanin
US5225435A (en) * 1990-05-18 1993-07-06 Yale University Soluble melanin
US5227459A (en) * 1990-05-18 1993-07-13 Yale University Synthetic melanin
US5260055A (en) * 1991-02-19 1993-11-09 John Imperante Fatty carboxylic silicone amine salts
US5260065A (en) 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
US5247055A (en) 1992-03-20 1993-09-21 Stenger Smith John D Accordion-like polymers for nonlinear applications
US5744125A (en) * 1993-08-19 1998-04-28 Yale University Cosmetic melanins
US6284234B1 (en) * 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents

Also Published As

Publication number Publication date
CA2547762C (en) 2012-06-19
US20050129633A1 (en) 2005-06-16
EP1701689B1 (de) 2010-02-10
EP1701689A1 (de) 2006-09-20
CA2547762A1 (en) 2005-06-30
DE602004025507D1 (de) 2010-03-25
WO2005058262A1 (en) 2005-06-30
US7935331B2 (en) 2011-05-03

Similar Documents

Publication Publication Date Title
ATE457160T1 (de) Vanillin-polymere zwecks verwendung zur verdunklung der haut
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE60314865D1 (de) Verfahren zur herstellung von modifiziertem polymer, danach erhaltenes modifiziertes polymer und kautschukzusammensetzung
DE502006000218D1 (de) Verfahren zur Herstellung von SiOC-verknüpften, linearen Polydialkylsiloxan-Polyoxyalkylen-Blockcopolymeren
ATE381334T1 (de) 2,5-substituiertetetrahydroisochinoline zur verwendung als 5-ht6 modulatoren
DE602005022859D1 (de) Heteroarylbenzamidderivate zur verwendung als glk-aktivatoren bei der behandlung von diabetes
DE602004015386D1 (de) Klebestruktur zur Befestigung auf der Haut
ATE433978T1 (de) 5,7-diaminopyrazolo 4,3-d pyrimidine zur verwendung in der behandlung von bluthochdruck
EP3620465C0 (de) Verbesserte verfahren zur herstellung, markierung und verwendung von mhc-multimeren
DE602006018936D1 (de) Flüssigkeit enthaltend trehalose zur verwendung bei der prävention von gewebeadhäsion
ATE506361T1 (de) Aryl- und heteroarylpiperidincarboxylatderivate, deren herstellung und deren verwendung in form von faah-enzyminhibitoren
EP1766086A4 (de) Verwendung von genexpressionsprofilen zur prognose der überlebensrate bei krebspatienten
DE502004011765D1 (de) Implantat zur Spreizung der Nasenflügel
DE60318744D1 (de) ZUSAMMENSETZUNG AUF BASIS VON 2-CYANOACRYLAT, VERFAHREN UND MITTEL ZUR EVALUIERUNG DER HuRTUNG DAVON
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
DE602004032465D1 (de) Referenzstandard zur charakterisierung von rosuvastatin
DE60329469D1 (de) Herzschrittmacher mit anpassbaren zeitfenstern zur detektion von arrhythmie
ATE319668T1 (de) Verfahren zur synthese von (2s)-indolin-2- carbonsäure, und verwendung in der synthese von perindopril
DE60325194D1 (de) Methoden zur verwendung von lamellaren körpern für therapeutische zwecke
DE602005007220D1 (de) Tetrahydropyridothiophenen zur verwendung in der behandlung von krebs
DE602004011674D1 (de) Promotormoleküle zur verwendung in pflanzen
ATE446299T1 (de) Verfahren zur herstellung von 7-ethyl-10- hydroxycamptothecin
DE602008005873D1 (de) Verwendung von 4-cyclopropylmethoxy-n-(3,5-dichlor-1-oxidopyridin-4-yl)-5-(methoxy)-pyridin-2-carboxamid zur behandlung von rückenmarksverletzungen
ATE372150T1 (de) Verwendung von speziellen polyolen zur kristallisationsinhibierung von oniumaldehyden bzw. -ketonen
NO20053903D0 (no) Nukleotidlipidesterderivater.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties